News & Publications Research Publications Core Bio Identifies HOX Transcription Factor Dominance in Huntington’s Disease and Demonstrates Network Reprogramming and Benefits with Its HOX Inhibitor COR-H800 in Transgenic MiceResearch Preprint | bioRxiv | November 2026 Read Publication Core Bio Introduces the Core Coefficient, the Component of Its REPROGRAM AI Platform That Quantifies Transcription Factor Functional DominanceResearch Preprint | bioRxiv | October 2026 Read Publication Conferences & Presentations Core Bio Presents New Findings on HOX Transcription Factors in Huntington’s Disease at CHDI 202520th Annual HD Therapeutics Conference | February 2025 Hear Presentation